Experimental treatment combination, immunotherapy, (pembrolizumab), and targeted chemotherapy, (trametinib) for lung cancer

Enter your info and the study team will contact you soon!
Your data is securely stored and only shared with the research team
Data is not saved in preview.
"Help us evaluate the effects of the combination of immunotherapy and targeted chemotherapy on non-small cell lung cancer"
Age:
18-100
Gender:
Any
Healthy Volunteers:
No
Keywords:
advanced lung cancer, metastatic lung cancer
Type:
Drug Study, Phase Ib
Investigator:
Description
This study will be looking at two cancer drugs – pembrolizumab (MK-3475) and trametinib. Pembrolizumab (MK-3475) is FDA approved for the treatment of metastatic melanoma and metastatic lung cancer. Trametinib (targeted chemotherapy) is FDA approved for unresectable (unable to be removed with surgery) or metastatic melanoma cancers. Pembrolizumab (MK-3475) and trametinib are considered experimental in combination for this indication.
Pembrolizumab (MK-3475) is a highly selective antibody (immunotherapy) that is designed to move in the blood stream and attach to the surface of some white blood cells (WBCs). After this happens, the combined MK-3475/WBCs may begin attacking your tumor.
Researchers hope that the combination of pembrolizumab and trametinib will be safely tolerated and increase the effect on your body’s ability to fight your cancer.
This study requires
Please contact for details
Who can participate?
Please contact for details
Benefits and risks of participating
You may not benefit from taking part in this research. The information we get from this study may help us to learn more about this study treatment, and this may help future cancer patients

Please contact for details concerning risks
Resources
Schedule
Study duration and period
Variable
Recruitment period
From Aug. 14, 2017
Location
UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817
Contact
Leigh Anne Morris

Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.


Sending

Send SMS with Study Info:

SMS Sent!

Share Study Info via Email:


E-mail Preview